Literature DB >> 17625449

Treatment for hepatitis C virus in injection drug users on opioid replacement therapy: a prospective multicentre study.

Barbara Belfiori, Alessandro Chiodera, Patrizia Ciliegi, Andrea Tosti, Franco Baldelli, Giuliano Stagni, Daniela Francisci.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17625449     DOI: 10.1097/01.meg.0000280175.79379.04

Source DB:  PubMed          Journal:  Eur J Gastroenterol Hepatol        ISSN: 0954-691X            Impact factor:   2.566


× No keyword cloud information.
  6 in total

Review 1.  Hepatitis infection in the treatment of opioid dependence and abuse.

Authors:  Thomas F Kresina; Diana Sylvestre; Leonard Seeff; Alain H Litwin; Kenneth Hoffman; Robert Lubran; H Westley Clark
Journal:  Subst Abuse       Date:  2008-04-28

2.  Causes of Death After Nonfatal Opioid Overdose.

Authors:  Mark Olfson; Stephen Crystal; Melanie Wall; Shuai Wang; Shang-Min Liu; Carlos Blanco
Journal:  JAMA Psychiatry       Date:  2018-08-01       Impact factor: 21.596

3.  Barriers to receiving hepatitis C treatment for people who inject drugs: Myths and evidence.

Authors:  Peter Higgs; Rachel Sacks-Davis; Judy Gold; Margaret Hellard
Journal:  Hepat Mon       Date:  2011-07       Impact factor: 0.660

4.  Association between hepatitis C virus and opioid use while in buprenorphine treatment: preliminary findings.

Authors:  Sean M Murphy; Dana Dweik; Sterling McPherson; John M Roll
Journal:  Am J Drug Alcohol Abuse       Date:  2015-01       Impact factor: 3.829

Review 5.  Critical issues in the treatment of hepatitis C virus infection in methadone maintenance patients.

Authors:  David M Novick; Mary Jeanne Kreek
Journal:  Addiction       Date:  2008-04-16       Impact factor: 6.526

6.  Addicts with chronic hepatitis C: difficult to reach, manage or treat?

Authors:  Barbara Zanini; Federica Benini; Marie Graciella Pigozzi; Patrizia Furba; Ernesto Giacò; Antonia Cinquegrana; Mariagrazia Fasoli; Alberto Lanzini
Journal:  World J Gastroenterol       Date:  2013-11-28       Impact factor: 5.742

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.